These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36055753)

  • 1. Role of cardiac α
    Kawakami S; Kambayashi R; Takada K; Aimoto M; Nagasawa Y; Takahara A
    J Pharmacol Sci; 2022 Oct; 150(2):67-73. PubMed ID: 36055753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Antiarrhythmic Action of the Na
    Kawakami S; Takada K; Aimoto M; Nagasawa Y; Kusakabe T; Kato K; Takahara A
    Biol Pharm Bull; 2023; 46(8):1120-1127. PubMed ID: 37532563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beat-by-beat QT interval variability, but not QT prolongation per se, predicts drug-induced torsades de pointes in the anaesthetised methoxamine-sensitized rabbit.
    Jacobson I; Carlsson L; Duker G
    J Pharmacol Toxicol Methods; 2011; 63(1):40-6. PubMed ID: 20451633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K201, a multi-channel blocker, inhibits clofilium-induced torsades de pointes and attenuates an increase in repolarization.
    Hasumi H; Matsuda R; Shimamoto K; Hata Y; Kaneko N
    Eur J Pharmacol; 2007 Jan; 555(1):54-60. PubMed ID: 17112502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vernakalant is devoid of proarrhythmic effects in the complete AV block dog model.
    Varkevisser R; van der Heyden MA; Tieland RG; Beekman JD; Vos MA
    Eur J Pharmacol; 2013 Nov; 720(1-3):49-54. PubMed ID: 24211677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AV-block and conduction slowing prevail over TdP arrhythmias in the methoxamine-sensitized pro-arrhythmic rabbit model.
    Varkevisser R; Vos MA; Beekman JD; Tieland RG; Van Der Heyden MA
    J Cardiovasc Electrophysiol; 2015 Jan; 26(1):82-9. PubMed ID: 25154623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the ion channel-blocking profile of the novel combined ion channel blocker AZD1305 and its proarrhythmic potential versus dofetilide in the methoxamine-sensitized rabbit in vivo.
    Carlsson L; Andersson B; Linhardt G; Löfberg L
    J Cardiovasc Pharmacol; 2009 Jul; 54(1):82-9. PubMed ID: 19528812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Torsadogenic potential of a novel remyelinating drug clemastine for multiple sclerosis assessed in the rabbit proarrhythmia model.
    Kawakami S; Nagasawa Y; Hagiwara-Nagasawa M; Omura K; Aimoto M; Takahara A
    J Pharmacol Sci; 2020 Nov; 144(3):123-128. PubMed ID: 32921393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: low torsadogenic potential despite QT prolongation.
    Eckardt L; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2002 Jan; 300(1):64-71. PubMed ID: 11752098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of E-4031-induced torsade de pointes by HMR1556 or ATX-II is not predicted by action potential short-term variability or triangulation.
    Michael G; Dempster J; Kane KA; Coker SJ
    Br J Pharmacol; 2007 Dec; 152(8):1215-27. PubMed ID: 17965747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anaesthetized rabbit with acute atrioventricular block provides a new model for detecting drug-induced Torsade de Pointes.
    Hagiwara M; Shibuta S; Takada K; Kambayashi R; Nakajo M; Aimoto M; Nagasawa Y; Takahara A
    Br J Pharmacol; 2017 Aug; 174(15):2591-2605. PubMed ID: 28547743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarisations.
    Carlsson L; Abrahamsson C; Andersson B; Duker G; Schiller-Linhardt G
    Cardiovasc Res; 1993 Dec; 27(12):2186-93. PubMed ID: 8313427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome.
    Diness TG; Yeh YH; Qi XY; Chartier D; Tsuji Y; Hansen RS; Olesen SP; Grunnet M; Nattel S
    Cardiovasc Res; 2008 Jul; 79(1):61-9. PubMed ID: 18367457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep anesthesia suppresses ventricular tachyarrhythmias in rabbit model of the acquired long QT syndrome.
    Inaba H; Hayami N; Ajiki K; Kunishima T; Watanabe H; Tsutsui K; Yamagishi N; Yamagishi S; Sugiura A; Mikamo T; Murakawa Y
    Circ J; 2011; 75(1):89-93. PubMed ID: 21139251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay between temporal and spatial dispersion of repolarization in the initiation and perpetuation of torsades de pointes in the chronic atrioventricular block dog.
    Smoczyńska A; Aarnink EW; Dunnink A; Bossu A; van Weperen VYH; Meijborg VMF; Beekman HDM; Coronel R; Vos MA
    Am J Physiol Heart Circ Physiol; 2021 Sep; 321(3):H569-H576. PubMed ID: 34355987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pH on nifekalant-induced electrophysiological change assessed in the Langendorff heart model of guinea pigs.
    Kazusa K; Nakamura Y; Watanabe Y; Ando K; Sugiyama A
    J Pharmacol Sci; 2014; 124(2):153-9. PubMed ID: 24451996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of K201 on repolarization and arrhythmogenesis in anesthetized chronic atrioventricular block dogs susceptible to dofetilide-induced torsade de pointes.
    Stams TR; Oros A; der Nagel Rv; Beekman JD; Chamberlin P; Dittrich HC; Vos MA
    Eur J Pharmacol; 2011 Dec; 672(1-3):126-34. PubMed ID: 22001562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beat-to-Beat variability of repolarization determines proarrhythmic outcome in dogs susceptible to drug-induced torsades de pointes.
    Thomsen MB; Volders PG; Beekman JD; Matz J; Vos MA
    J Am Coll Cardiol; 2006 Sep; 48(6):1268-76. PubMed ID: 16979017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased short-term variability of repolarization predicts d-sotalol-induced torsades de pointes in dogs.
    Thomsen MB; Verduyn SC; Stengl M; Beekman JD; de Pater G; van Opstal J; Volders PG; Vos MA
    Circulation; 2004 Oct; 110(16):2453-9. PubMed ID: 15477402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitorsadogenic effects of ({+/-})-N-(2,6-dimethyl-phenyl)-(4[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazine (ranolazine) in anesthetized rabbits.
    Wang WQ; Robertson C; Dhalla AK; Belardinelli L
    J Pharmacol Exp Ther; 2008 Jun; 325(3):875-81. PubMed ID: 18322148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.